Measurement of liver fat by MRI and its reduction by dexfenfluramine in NIDDM

International Journal of Obesity

Volumn 21, Issue 4, 1997, Pages 274-279

  Marks, S J ^a,c   Moore, N R ^b   Ryley, N G ^b   Clark, M L ^a   Pointon, J J ^b   Strauss, B J G ^c   Hockaday, T D R ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

Dexfenfluramine; Insulin sensitivity; Liver biopsy; Liver fat; Visceral adipose tissue

Indexed keywords

C PEPTIDE; DEXFENFLURAMINE; GLUCOSE; INSULIN; LIPID; SULFONYLUREA;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030990576     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800400     Document Type: Article

References (34)

1. Armellini F, Zamboni M, Castelli S, Micciolo R, Mino A, Turcato E, Rigo L, Bergamo-Andreis IA, Bosello O. Measured and predicted total and visceral adipose tissue in women. Correlations with metabolic parameters. Int J Obes 1994; 18: 641-647.
2. Seidell JC, Bjorntorp P, Sjostrom, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990; 39 (9): 897-901.
3. Fujioka S, Matsuzawa Y, Tokunaya K, Kawamoto T, Kobatake T, Keno Y, Kotani K, Yoshida S, Tarui S. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 1991; 15: 853-859.
4. Lennen R, Van der Kooy K, Seidell J, Deurenberg P. Visceral fat accumulation measured by magnetic resonance imaging in obese men and women. Atherosclerosis 1992; 94: 171-181.
5. Bjorntorp P. Adipose tissue in obesity. In: Bery SM, Bloudheim SH, Eliahou HE (eds). Recent Advances in Obesity Research. Vol. 5. Libby: London, England, 1987. pp 60-65.
6. Bevilaqua S, Bonadonna R, Buzzigoli G. Acute elevation of free fatty acid levels lead to hepatic insulin resistance in obese subjects. Metabolism 1987; 36: 502-504.
7. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes 1995; 19: 846-850.
8. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990; 99: 1408-1413.
9. Needleman L, Kurtz AB, Ritkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease with accuracy of pattern recognition and grading. AJR 1986; 146: 1011-1015.
10. Alpern MB, Lawson TL, Foley WD, Perlman SJ, Reif LJ, Arevalos E, Rimm AA. Focal hepatic masses and fatty infiltration detected by enhanced dynamic CT. Radiology 1986; 158: 45-49.
11. Cooper RA, Shuter B, Ruppin DC, Lunzer MR, Fidge N. The estimation of liver triglyceride content by 133 Xe clearance. Int J Nucl Med Biol 1982; 9: 17-23.
12. Yates CH, Streight RA. Focal fatty infiltration of the liver simulating metastatic disease. Radiology 1986; 159: 83-84.
13. Adkins MC, Halvorson Jr RA, duCret RP. CT evaluation of atypical hepatic fatty metamorphosis. J Comput Assist Tomogr 1990; 14: 1013-1015.
14. Stark DD, Goldberg HI, Moss AA, Bass NM. Chronic liver disease: evaluation by magnetic resonance. Radiology 1984; 150: 149-151.
15. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984; 153: 189-194.
16. Mitchell DG, Kim I, Chang TS, Vititski S, Consigny PM, Saponaro SA, Ehrick SM, Rifkin MD, Rubin R. Chemical shift- phase difference and suppression magnetic resonance imaging techniques in animals, phantoms and humans. Invest Radio 1991; 26: 1041-1052.
17. Longo R, Ricci C, Masutt F, Vidimai R, Croce LS, Bereich L, Tiribelli C, Dalla Palmac. Fatty infiltration of the liver: quantification by 'H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993; 28: 297-302.
18. Marks SJ, Dixon RM, Styles P, Ryley NG, Hockaday TD. Problems associated with using in vivo proton ('H) magnetic resonance spectroscopy to quantify liver fat. Asia Pacific J Clin Nutr 1995; 4: 195-198.
19. Hoyumpa AM Jr, Green HL, Dunn GD. Fatty liver, biochemical and clinical considerations. Am J Dig Dis 1975; 20: 1142-1170.
20. Marks SJ, Moore NR, Clark ML, Strauss BJG, Hockaday TDR. Reduction of visceral adipose tissue and improvement of metabolic indices: effect of dexfenfluramine in NIDDM. Obes Res 1996; 4 (1): 1-7.
21. Baues DR, Gildendale DJ, Bydder GM, Collins AG, Firmin DN. Respiratory ordered phase encoding (ROPE), a method for reducing motion artifacts in MR imaging. J CAT 1985; 9: 835-838.
22. Felmlee JP, Ehman RL. Spatial presaturation; a method for suppressing flow artifacts and improving depiction of vascular anatomy in the MR imaging. Radiology 1987; 164: 559-564.
23. Frahm J, Haase A, Hanicke W, Matthaei D, Bomsdorf H, Helzel T. Chemical Shift Selective MR imaging using a whole body magnet. Radiology 1985; 156: 441-444.
24. Folch J, Lees M, Sloane SG. A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
25. Fielding BA, Humphries SM, Allman RFC, Frayn KN. Monodi-and triacylglycerol concentrations in human plasma; effect of heparin injection and of a high-fat meal. Clinica Chimica Acta 1993; 216: 167-173.
26. Himsworth H. Diabetes Mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet 1936; 1: 127-130.
27. Kai E, Ishizaki M, Suzuki Y, Ishida M, Noborizaka Y, Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people. J Hum Hypertens 1995; 9 (2): 101-105.
28. Adner N, Nygren A. Insulin sensitivity in alcoholics in a withdrawal state. J Inter Med 1990; 228: 59-64.
29. Krai JG, Schaffner F, Pierson RN, Wang J. Body fat topography as an independent predictor of liver fat. Metabolism 1993; 42 (5): 548-551.
30. Goto T, Onuma T, Takebe K, Krai JG. The influence of fatty liver on insulin clearance and insulin. uln resistance in nondiabetic Japanese subjects. Int J Obes 1995; 19: 841-845.
31. Stark DD, Bass NM, Moss AA, Bacon BR, McKerrow JH, Cann CE, Brito A, Goldberg HI. Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology 1983; 148: 743-751.
32. Eisele JW, Barker EA, Smuckler EA. Lipid content in the liver of fatty metamorphosis of pregnancy. Am J Pathol 1975; 81: 545-560.
33. Heiken JP, Lee JKT, Dixon WT. Fatty infiltration of the liver: evaluation by proton Spectroscopic imaging. Radiology 1985; 157: 707-710.
34. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.